Schizophrenia Research Forum - A Catalyst for Creative Thinking


Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B, Minassian A, Becker O, Cooper J, Perry W, Lefebvre M, Gonzales J, Hadley A. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry. 2010 Oct 1 ; 68(7):678-80. Pubmed Abstract

Comments on News and Primary Papers


Primary Papers: Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

Comment by:  Lewis Opler (Disclosure)
Submitted 20 July 2012
Posted 24 July 2012
  I recommend this paper

This is an important paper. See also earlier studies by Feifel and colleagues (2010) and Pedersen and colleagues (2011).

References:

Feifel D, Macdonald K, Nguyen A, Cobb P, Warlan H, Galangue B, Minassian A, Becker O, Cooper J, Perry W, Lefebvre M, Gonzales J, Hadley A. Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients. Biol Psychiatry . 2010 Oct 1 ; 68(7):678-80. Abstract

Pedersen CA, Gibson CM, Rau SW, Salimi K, Smedley KL, Casey RL, Leserman J, Jarskog LF, Penn DL. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia. Schizophr Res . 2011 Oct ; 132(1):50-3. Abstract

View all comments by Lewis Opler